ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

ASCO GI 2023 Key Studies

ASCO GI 2023 Conference Coverage

R. Kim, R. Mehta

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

ASCO® 2024 Insights: "Summary of the PASS-01 Trial - 1L FOLFIRINOX v…

ecancer

J. Knox

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreatic Ad…

2024 ASCO® Annual Meeting Insights Hub

J. Knox

Perspectives on the Recent FDA Approval of NALIRIFOX in Frontline Me…

UCLA Health

Z. Wainberg

ASCO® 2024 Insights: "EXPEL-PANC - A Ph2 Study of BXCL701 + Pembro i…

2024 ASCO® Annual Meeting Insights Hub

B. Weinberg

Clinical Takeaways in From Recent Key Trials in Pancreatic Cancer

Hani Babiker

GI Oncology Year in Review: Metastatic Pancreatic Cancer - NAPOLI-3 …

Yale Cancer Center

J. Lacy

Updates on Pancreatic Cancer - 2023 ASCO® Direct Philadelphia

Total Health

D. Lin

FDA Approval of Liposomal Irinotecan/NALIRIFOX in 1L Metastatic Panc…

Shubham Pant

Augmenting Standard Treatment Options in Pancreatic Cancer

Rachna Shroff

ASCO® 2024 Review: Clinically-Impactful Abstracts in Pancreatic Canc…

Nebraska Oncology Society

R. Safyan

ASCO® 2023 Insights: "NAPOLI 3 Analysis of 1L NALIRIFOX vs. Gem + na…

ecancer

E. O’Reilly

ASCO GI 2023 NAPOLI-3 Randomized, Open-Label Phase 3 Study: Liposoma…

ASCO GI 2023 Conference Coverage

Z. Wainberg

2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 NAPOL…

Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

Z. Wainberg

Updates on Pancreatic Cancer Treatment

The University of Kansas Cancer Center

A. Kasi

Clinical Implications & Highlights of Recent Pancreatic Cancer Trial…

Total Health

J. Kratz

ASCO 2022 Non-Colorectal Cancer Updates

Total Health

D. Catenacci